Search results
Novavax stock doubles after Sanofi deal marks 'new chapter' for company
AOL· 6 hours agoNovavax stock (NVAX) skyrocketed on Friday, gaining as much as 120% on the news French drug and vaccine giant Sanofi (SNY) would invest $1.2 billion in ...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 3 hours ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
Novavax strikes $1.2 billion deal with Sanofi in major turnaround
Axios· 3 hours agoDriving the news: Novavax will receive an upfront payment of $500 million and up to $700 million in...
Novavax Stock More Than Doubles After Sanofi Vaccine-Licensing Deal
The Wall Street Journal· 6 hours agoNovavax shares (NVAX) surged after the vaccine maker said it had struck a licensing deal worth up to...
Novavax and Sanofi Announce Co-exclusive Licensing Agreement to Co-commercialize COVID-19 Vaccine...
WKRN Nashville· 15 hours ago...worldwide (except in countries with existing Advance Purchase Agreements and in India, Japan and South Korea where Novavax has existing partnership agreements); a sole license to Novavax's adjuvanted COVID-19 vaccine for use in combination with Sanofi's flu vaccines while Novavax retains the...
Novavax gets a lifeline with Sanofi vaccine pact
BioPharma Dive via Yahoo Finance· 11 hours agoSanofi will ally with the under-pressure biotech, paying $500 million upfront for rights to co-commercialize Novavax’s COVID shot and develop combination...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 8 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide ...
Novavax Sheds Going Concern Warning as NVAX Stock Pops on Sanofi Licensing Deal
InvestorPlace· 4 hours agoCovid-19 vaccine. The agreement will also provide Sanofi with a sole license to the vaccine for use...
Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine
RTT News· 7 hours agoNovavax also announced a co-exclusive licensing agreement with Sanofi to co-commercialize Covid-19 vaccine and develop ...
UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
Reuters via Yahoo Finance· 14 hours agoNovavax on Friday removed doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-< ...